Oct 10, 2016 at 15:48 | Source: CNBC-TV18
Prakash Gaba of prakashgaba.com is of the view that one may hold GlaxoSmithKline Pharmaceuticals.
Sep 26, 2016 at 14:38 | Source: Moneycontrol.com
With maintaining neutral rating on Glaxosmithkline Pharmaceutical, Credit Suisse slashed target price to Rs 2,850 as it continues to struggle with price control & supply constraints in some products. It also reduced FY17 earnings per share by 41 percent.
Sep 15, 2016 at 19:49 | Source: Moneycontrol.com
Some investors shy away from buying stocks that have high prices. The belief is unfounded.
Jun 08, 2016 at 10:58 | Source: CNBC-TV18
Andrew Aristidou, CFO and ED Finance, GSK Pharma, speaks about the companys new launches and why GSK Pharma is in no rush to delist in India.
Mar 21, 2016 at 11:24 | Source: CNBC-TV18
Ajay Bodke of Prabhudas Lilladher is of the view that one can look at Ashok Leyland, Tata Motors, GlaxoSmithKline Consumer Healthcare, Britannia Industries and Sun Pharma.
Feb 11, 2016 at 08:13 | Source: CNBC-TV18
SBI | Tata Motors | HUL | Bharti Airtel | Cipla | ACC | Ambuja Cements | Emami | NHPC | Aurobindo Pharma | Visa Steel | Ruchi Soya | Venus Remedies | Financial Technologies | Tata Global | BL Kashyap | Asahi India Glass | IVRCL | Alstom T&D India | GSK Pharma and Capital First are stocks, which are in the news today.
Feb 10, 2016 at 17:00 | Source: CNBC-TV18
In an interview with CNBC-TV18, A Vaidheesh, VP, South Asia and MD of India GSK said that companys growth is in-line with the market and expects margins to outperform the industry average this fiscal.
Sep 30, 2015 at 19:22 | Source: PTI
The company has completed its transaction with Novartis Healthcare Pvt Ltd on Wednesday whereby it has acquired Novartis' vaccines business and divested its marketed oncology portfolio to Novartis India, GlaxoSmithKline Pharmaceuticals said in a filing to the BSE.
Sep 01, 2015 at 13:39 | Source: PTI
This acquisition fortifies the company's position with two opiates manufacturing facilities in Port Fairy and Latrobe (both in Australia) complementing its API manufacturing footprint globally, Sun Pharma said in a statement.
Sep 01, 2015 at 10:01 | Source: Moneycontrol.com
"Sun Pharma today begins the integration of its Opiates business in Australia following the successful completion of this acquisition from GSK (announced in March 2015)," said the country's largest drug maker in its filing.